Package leaflets (PLs) have been legally required to accompany medicines in the EU since 1999. Despite the best intentions and efforts, however, they are generally not well-received by the public for whom they are intended. This paper picks up on the challenges that medical regulatory writers face in producing quality PLs using the official PL template when research indicates that patients would prefer a more personalised genre that incorporated their experiences and knowledge. This paper advocates greater inclusion of patients' perspectives, as this is currently achievable given the current legislation. The paper also notes the tantalising prospect of replacing the template with a set of recommendations that draws on knowledge of what works best for patients.
Introduction
This paper addresses the question: how can medical writers, for whom best practice involves writing for the reader in a 'clear, accurate, and engaging' way, 1 accomplish this in a constrained, regulated genre such as the package leaflet (PL) which accompanies medications in the EU? The paper derives from my PhD dissertation, 2 which used discourse analysis to demonstrate how attention to patients' needs is possible in PLs; the primary focus of the present paper is on practical implications for medical writing professionals.
The dilemma: Between a rock (of regulation) and a hard place (of patients' expectations)
Since 1999, all medicines available to patients in the EU have been legally required to be accompanied by PLs, which provide information on medicines and how to use them. Although these texts are important for patients' health and safety, many patients do not value them. This is due to a number of factors, but the one that will be addressed here is patients' belief that PLs are not written with them in mind. 3 They deem PLs instead to be written for professional purposes, such as meeting legal requirements and avoiding litigation, 4 and consider their own perspectives and knowledge to be absent from these texts. 5 Whilst genres are normally in a state of flux, 6 the PL is a particularly constrained genre and the scope that medical writers have for improving it is impacted in a number of ways. Firstly, the PL's status as a legal, regulated genre means that a conservative approach to genre development is most likely, as any delays to approving PLs due to alternative, unapproved wordings, for example, could delay the release of products and be expensive for pharmaceutical companies. Secondly, since 1998, a template produced by the European Medicines Agency (EMA) stipulates particular content, structure, headings, and statements for PLs. The template has been revised over the years: the most recent template, dated June 2015, is called Version 9.1. Ostensibly, the template provides writers with a number of advantages. It helps to ensure that all information is present in a particular order, ensures linguistic consistency across PLs which is likely to facilitate regulatory processes, and essentially 'takes many decisions out of the hands of medical writers'. 8 However, this is also a potential disadvantage as 'templates tend to stifle innovation', 9 leading to very standardised texts. Moreover, the quality of the template has also been identified as problematic, 8 with the implication that texts that are based on the template reproduce its weaknesses. The focus of this paper is on PLs that are regulated through centralised procedures by EMA. This is worth mentioning, as PLs in the EU may be regulated either nationally or centrally at European level. In Britain, for example, PLs regulated at national level by the Medicines and Healthcare Products Regulatory Agency (MHRA) are only required to follow the set content and order specified in the legislation, 10 whereas PLs that are regu- This assumption of patient laity may not, of course, correspond with the actual reader of the PL, as patients are increasingly using the internet to equip themselves with information. Some chronic patients, in particular, gain knowledge of their condition to such an extent that they should be considered semi-experts, even experts, on their condition. 16 At the same time, however, there are also readers of PLs with low health literacy levels who need information to be expressed as simply as possible. In other words, patients exist along a broad epistemic spectrum, and although it is best practice to express information as clearly as possible, not everyone reading PLs is lay. The leaflet format as it currently stands does not make it possible to address various levels of health literacy. At a more general level, there is lack of recognition in PLs of other aspects of patients' heterogeneity and humanity. Individual patients read PLs and find that the 'umbrella concept' of the audience does not reflect the intensely personal nature of their illness experience. 17 Perhaps patients have come to expect patient-centred communication not only in the clinical setting but also in written communication. In any case, this lack of focus on the patient in PLs must be taken seriously, not only to address patients' dissatisfaction, but also because of proven educational benefits: the more targeted and individualised medical leaflets are, the more motivated patients are to read them and the better they are at recalling their content. 18 The challenge for the regulatory writer is thus the following: given the template and the mass communication format of the leaflet format, how does one make PLs more personalised?
On meeting regulatory demands and demands from patients
The approach to improving PLs that is outlined in this paper is a pragmatic one. It proposes producing PLs in accordance with the template -which means that writers can more readily adopt these suggestions -whilst adding content couched in patientfriendly language that integrates patients' Moreover, it is possible to produce better quality PLs whilst using the template. Pander Maat & Lentz, 20 for example, showed that PLs that met the template's requirements were improved (made more usable) using principles of document design. For improvements to take place, however, there needs to be a context in which improvements can take place. The context that has impeded this genre's evolution can be addressed in two ways. The bottom-up approach involves pharmaceutical companies and regulatory writers making it a priority to include patients' perspectives to a far greater degree in the texts they produce. Such PLs would be better at engaging their publics, resulting in an increase in the safety of the medication, more ethical communication, and potentially improved customer relations. The top-down approach involves regulatory authorities such as EMA promoting more patient-oriented communication in PLs, with possible implications for changes in legislation. The integration of patients' perspectives in PLs would be an extension of EMA's growing focus on patient involvement, as is evident, for example, in EMA's use of feedback from user testing (comprehensibility tests) of existing PLs to refine the template 7 and the production of a webpage for patients and carers. 21 No doubt a combination of the top-down and bottom-up approaches would be the most effective for the bold changes required in this genre.
The following strategies can help support the production of PLs where patients' perspectives and knowledge are included and their needs are met: British PLs, three of which were regulated by EMA and 12 of which were regulated by MHRA, some aspects of patient centeredness were evident in a limited number of constructions of risk, trust and the patient (see Table 1 ), thus indicating that patient-centred communication, although rare, was nevertheless possible in PLs. Acquaintance with alternative health communicative frameworks or paradigms could provide the producers of PLs with inspiration regarding how to integrate aspects that reflected patients' needs, experiences and knowledge to a much greater degree.
• Knowing the patient group: In relation to meeting patients' needs, the recent paper by Lang and Esser 22 in this journal on how to incorporate empathy is very valuable. The point made about using online self-help groups and patient forums to acquire better understanding of patients' perspectives is particularly useful. Patient organisations' websites for particular conditions could also provide meaningful insights into the kind of content that would make PLs more focused on particular patient groups' needs, perspectives and experiences.
Whilst these suggestions can help to integrate patients' perspectives in PLs, there are clearly challenges involved in producing effective mass communication texts for individuals. Given the tension between mass communication texts and meeting individual needs, an exciting avenue that warrants further exploration is the possibility of supplementing the PL with online alternatives (e-leaflets), which could be tailored to the individual patient and which offered patients choice regarding preferred levels of detail and specificity. 
Conclusion
It is clear that PLs, as they are written for patients, ought to meet patients' needs, and that more should be done to ensure that these texts achieve that goal. The approach that has been outlined in this paper involves continued use of the template, while additional content is included to help reflect patients' perspectives and knowledge and meet patients' needs. However, given that the template has been revised many times and patients remain dissatisfied with PLs, it may be advisable in the long term to consider replacing the template with a set of recommendations that integrated the findings of research and patient feedback, and allowed regulatory writers greater freedom to respond to patients' needs. 20, 23 Improvements to PLs, however they take place, would help medical regulatory writers produce PLs knowing that these texts were appreciated by their recipients. Pharmaceutical companies could also benefit from more personalised PLs, as patients currently attribute poor communication in PLs to 'big pharma's' lack of interest in their well-being. 4 But the biggest beneficiaries would be patients who found that their needs were better met in PLs. This would lead to greater levels of satisfaction with these texts, as well as likely positive effects for patient empowerment, patient education, and patient health and safety.
